Carregant...
Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke
OBJECTIVE: Inhibitors of the voltage‐gated K(+) channel Kv1.3 are currently in development as immunomodulators for the treatment of autoimmune diseases. As Kv1.3 is also expressed on microglia and has been shown to be specifically up‐regulated on “M1‐like” microglia, we here tested the therapeutic h...
Guardat en:
| Publicat a: | Ann Clin Transl Neurol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817832/ https://ncbi.nlm.nih.gov/pubmed/29468176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.513 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|